Matches in SemOpenAlex for { <https://semopenalex.org/work/W2469930511> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2469930511 endingPage "A48" @default.
- W2469930511 startingPage "A48.1" @default.
- W2469930511 abstract "Background There is a wide range of therapeutic interventions proposed for the symptomatic treatment of Huntington's disease (HD). However, the majority of therapeutic decisions are supported by a low level of evidence.Aims To characterise the patterns of prescription and therapeutic indications in a HD population across European countries.Methods Monitored data of the REGISTRY study from 2004 to 2007 were selected. Demographic, clinical phenotype, number of CAG repeats and medication were analysed. The global and national frequencies of standardised therapeutic indications and of the corresponding pharmacological agents were estimated. The project was approved by the Scientific and Bioethics Advisory Committee of the EHDN.Results 1569 participants from 13 European countries were included. Women: 53.7%; mean age±SD 49.6±12.1; mean age of disease onset±SD 42.3±11.6. Antipsychotics and antidepressant drugs were the most frequent prescribed drugs (n=1182). Depression (734 or 46.7% of patients) and chorea/dyskinesia (675 or 43.0% of patients) were the most frequent therapeutic indications in 12/13 countries and the two most frequent indications in 9/13 countries. Overall, the most frequently used drugs for depression were escitalopram/citalopram (n=236, 32.2%) and paroxetine (n=159, 21.7%). For chorea/dyskinesia the most frequent options were tiapride (n=197, 21.9%) and tetrabenazine (n=163, 18.1%). In each indication, the frequency of each of these drugs varied across countries.Conclusions Depression and chorea/dyskinesia were the most frequent therapeutic indications in HD but with different treatment strategies across Europe. Treatment of clinical relevant symptoms of HD like apathy, irritability and cognitive impairment are not being prioritised by clinicians." @default.
- W2469930511 created "2016-07-22" @default.
- W2469930511 creator A5035961119 @default.
- W2469930511 creator A5046283901 @default.
- W2469930511 creator A5067113888 @default.
- W2469930511 date "2010-09-01" @default.
- W2469930511 modified "2023-09-26" @default.
- W2469930511 title "L02 Prescription patterns for Huntington's disease in Europe: results from the REGISTRY observational study" @default.
- W2469930511 doi "https://doi.org/10.1136/jnnp.2010.222687.2" @default.
- W2469930511 hasPublicationYear "2010" @default.
- W2469930511 type Work @default.
- W2469930511 sameAs 2469930511 @default.
- W2469930511 citedByCount "1" @default.
- W2469930511 countsByYear W24699305112016 @default.
- W2469930511 crossrefType "journal-article" @default.
- W2469930511 hasAuthorship W2469930511A5035961119 @default.
- W2469930511 hasAuthorship W2469930511A5046283901 @default.
- W2469930511 hasAuthorship W2469930511A5067113888 @default.
- W2469930511 hasConcept C118552586 @default.
- W2469930511 hasConcept C126322002 @default.
- W2469930511 hasConcept C139719470 @default.
- W2469930511 hasConcept C162324750 @default.
- W2469930511 hasConcept C187212893 @default.
- W2469930511 hasConcept C23131810 @default.
- W2469930511 hasConcept C2426938 @default.
- W2469930511 hasConcept C2776284327 @default.
- W2469930511 hasConcept C2776867660 @default.
- W2469930511 hasConcept C2777828372 @default.
- W2469930511 hasConcept C2778868616 @default.
- W2469930511 hasConcept C2779134260 @default.
- W2469930511 hasConcept C2779177272 @default.
- W2469930511 hasConcept C2779583969 @default.
- W2469930511 hasConcept C2908647359 @default.
- W2469930511 hasConcept C513476851 @default.
- W2469930511 hasConcept C558461103 @default.
- W2469930511 hasConcept C71924100 @default.
- W2469930511 hasConcept C98274493 @default.
- W2469930511 hasConcept C99454951 @default.
- W2469930511 hasConceptScore W2469930511C118552586 @default.
- W2469930511 hasConceptScore W2469930511C126322002 @default.
- W2469930511 hasConceptScore W2469930511C139719470 @default.
- W2469930511 hasConceptScore W2469930511C162324750 @default.
- W2469930511 hasConceptScore W2469930511C187212893 @default.
- W2469930511 hasConceptScore W2469930511C23131810 @default.
- W2469930511 hasConceptScore W2469930511C2426938 @default.
- W2469930511 hasConceptScore W2469930511C2776284327 @default.
- W2469930511 hasConceptScore W2469930511C2776867660 @default.
- W2469930511 hasConceptScore W2469930511C2777828372 @default.
- W2469930511 hasConceptScore W2469930511C2778868616 @default.
- W2469930511 hasConceptScore W2469930511C2779134260 @default.
- W2469930511 hasConceptScore W2469930511C2779177272 @default.
- W2469930511 hasConceptScore W2469930511C2779583969 @default.
- W2469930511 hasConceptScore W2469930511C2908647359 @default.
- W2469930511 hasConceptScore W2469930511C513476851 @default.
- W2469930511 hasConceptScore W2469930511C558461103 @default.
- W2469930511 hasConceptScore W2469930511C71924100 @default.
- W2469930511 hasConceptScore W2469930511C98274493 @default.
- W2469930511 hasConceptScore W2469930511C99454951 @default.
- W2469930511 hasIssue "Suppl 1" @default.
- W2469930511 hasLocation W24699305111 @default.
- W2469930511 hasOpenAccess W2469930511 @default.
- W2469930511 hasPrimaryLocation W24699305111 @default.
- W2469930511 hasRelatedWork W2003686381 @default.
- W2469930511 hasRelatedWork W2009365385 @default.
- W2469930511 hasRelatedWork W2134794586 @default.
- W2469930511 hasRelatedWork W2297652426 @default.
- W2469930511 hasRelatedWork W2400272258 @default.
- W2469930511 hasRelatedWork W2414239462 @default.
- W2469930511 hasRelatedWork W2469930511 @default.
- W2469930511 hasRelatedWork W3134170999 @default.
- W2469930511 hasRelatedWork W3158232277 @default.
- W2469930511 hasRelatedWork W3213635430 @default.
- W2469930511 hasVolume "81" @default.
- W2469930511 isParatext "false" @default.
- W2469930511 isRetracted "false" @default.
- W2469930511 magId "2469930511" @default.
- W2469930511 workType "article" @default.